Clin2
NCT04834869Possibly a fitRecruiting

Track safety after COVID-19 vaccination in adults

Adverse Reaction to VaccineCOVID19 Vaccine

Part of Infections, Lungs & breathing clinical trials.

This study follows adults who have already received a COVID-19 vaccine to monitor side effects and safety over time. Your participation helps researchers understand how the vaccine affects different people who are at higher risk due to their work.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be an adult (18 years or older).
  • You must be able to give informed consent on your own.
  • You must be a healthcare worker (HCW), an office/outreach worker (OA), or a student/trainee (ST).
  • You must have already received a COVID-19 vaccine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07798648Recruiting· Phase 3
COVID-19 vaccine study for children and adults

This study tests a COVID-19 vaccine in children and adults. It may help protect against COVID-19.

Homestead, Florida
NCT07730450Recruiting· Phase 4
COVID-19 vaccine study for healthy adults aged 18 to 64

This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.

Walnut Creek, California
NCT06585241Recruiting· Phase 4
Study of Updated COVID-19 Vaccines for High-Risk Groups

This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.

Atlanta, Georgia
NCT05212792Recruiting
Study genes after COVID vaccine side effects

This study looks at genetic information to better understand why some people develop serious side effects after a COVID-19 vaccine, such as GBS, blood clotting with low platelets (VITT/TTS), or heart inflammation (myocarditis/pericarditis). Your information may help researchers learn who is at higher risk and improve future safety.

Vancouver, British Columbia
NCT06810934Recruiting· Phase 1/Phase 2
New COVID-19 vaccine study for those with prior mRNA vaccines

This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.

Los Angeles, California
NCT04871932Recruiting
Study of immune response to a COVID-19 vaccine

This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.

Shanghai

Hear when a new Adverse Reaction to Vaccine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.